BI-RADS 3 lesions are classified as probably benign, with less than 2% risk of malignancy.
However, many patients ask:
“At what point does BI-RADS 3 require biopsy?”
Understanding progression criteria is essential for safe and confident management.
What Is BI-RADS 3?
BI-RADS 3 indicates:
- Very low cancer risk (<2%)
- Short-term imaging follow-up recommended
- No immediate biopsy needed
Typical examples include:
- Small oval circumscribed masses
- Stable fibroadenoma-like lesions
- Probably benign complicated cysts
Follow-up is structured and evidence-based.
When Should a BI-RADS 3 Lesion Be Upgraded?
A BI-RADS 3 lesion may require biopsy if:
1️⃣ Significant Growth
- Increase in size ≥20% in 6 months
- Progressive enlargement on serial imaging
Growth is the most common reason for upgrade.
2️⃣ Morphologic Change
- Margins become irregular
- Shape changes from oval to irregular
- New posterior shadowing develops
Morphology matters more than size alone.
3️⃣ New Suspicious Features
- Internal vascularity increases
- Architectural distortion appears
- Associated suspicious calcifications
These findings may prompt reclassification to BI-RADS 4.
Growth vs Stability
Stable lesions over:
- 6 months
- 12 months
- 24 months
Are typically downgraded to benign.
Most BI-RADS 3 masses do not require biopsy.
Counseling Perspective
Patients often feel anxious about “waiting.”
It helps to explain:
“BI-RADS 3 follow-up is a safety strategy. We monitor for change. If anything evolves, we act early.”
In clinical practice, the majority of BI-RADS 3 lesions remain stable.
Unnecessary biopsy can cause avoidable anxiety and cost.
Final Thoughts
BI-RADS 3 requires biopsy only when growth, morphologic change, or suspicious features develop.
Careful follow-up is not neglect — it is precision.
Understanding when to biopsy helps patients feel reassured while maintaining vigilance.
